サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1220018

LAMEAリアルワールドエビデンスソリューションの市場規模、シェア、産業動向分析レポート：コンポーネント別、治療分野別、エンドユーザー別、用途別、国別、成長予測、2022年～2028年

LAMEA Real World Evidence Solutions Market Size, Share & Industry Trends Analysis Report By Component, By Therapeutic Area, By End-user, By Application, By Country and Growth Forecast, 2022 - 2028
出版日: | 発行: KBV Research | ページ情報: 英文 114 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
LAMEAリアルワールドエビデンスソリューションの市場規模、シェア、産業動向分析レポート：コンポーネント別、治療分野別、エンドユーザー別、用途別、国別、成長予測、2022年～2028年
出版日: 2023年01月31日
発行: KBV Research
ページ情報: 英文 114 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ラテンアメリカ、中東・アフリカのリアルワールドエビデンスソリューション市場は、予測期間（2022-2028年）に10.7%のCAGRで市場成長を示すことになります。

地域のヘルスケア産業の将来は、いくつかの要素によって形成されており、そのため動向が変化しています。ヘルスケアコストの上昇、人口および疾病の人口動態の変化、ヘルスケアの質の重視、医療データのデジタル化、地域の臨床・経済データに対する需要の高まり、医療業界における世界的動向の全般的影響などがその要因です。しかし、同地域がRWEの恩恵を十分に受けるためには、RWEが医療の意思決定にもたらす価値の受容や、利害関係者間の信頼醸成などの障害を克服する必要があります。その他の特典として、RWEを生成するためのデータベースの妥当性・信頼性の確立、ローカルデータ生成への投資、技術力の向上が挙げられます。これらの要因は、患者の機密を保護しながら、高品質のRWE研究を行うことをさらに促進するでしょう。このようなヘルスケア分野の高まりは、LAMEAにおけるリアルワールドエビデンスソリューション市場の需要を促進するでしょう。

2021年のLAMEA国別リアルワールドエビデンスソリューション市場は、ブラジル市場が支配的であり、2028年まで支配的な市場であり続けるだろう；それにより、2028年までに9億3,300万米ドルの市場価値を達成します。アルゼンチン市場は、（2022～2028）期間に11.3%のCAGRを表示しています。また、UAE市場は2022年～2028年の間に10.4%のCAGRを示すと予想されます。

コンポーネントに基づき、市場はサービスおよびデータセットに区分されます。治療分野に基づいて、市場は腫瘍学、心臓学、神経学、糖尿病、呼吸器学、その他に区分されます。エンドユーザーに基づいて、市場はヘルスケア企業、ヘルスケアペイヤー、ヘルスケアプロバイダ、その他に区分されます。用途別に見ると、市場は医薬品開発・承認、医療機器開発・承認、償還・補償・規制上の意思決定、市販後安全・有害事象モニタリングに区分されます。国別に見ると、市場はブラジル、アルゼンチン、UAE、サウジアラビア、南アフリカ、ナイジェリア、その他のLAMEAに区分されています。

目次

第1章 市場の範囲と調査手法

  • 市場の定義
  • 目的
  • 市場規模
  • セグメンテーション
    • LAMEAのリアルワールドエビデンスソリューション市場、コンポーネント別
    • LAMEAリアルワールドエビデンスソリューション市場、治療分野別
    • LAMEAリアルワールドエビデンスソリューション市場、エンドユーザー別
    • LAMEAのリアルワールドエビデンスソリューション市場：用途別
    • LAMEAのリアルワールドエビデンスソリューション市場：国別
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要説明
      • 市場のシナリオと構成
  • 市場に影響を与える主な要因
    • 市場の促進要因
    • 市場の抑制要因

第3章 実世界証拠ソリューション市場で展開されている戦略

第4章 LAMEAの実世界証拠ソリューション市場：コンポーネント別

  • LAMEAのサービス市場：国別
  • LAMEAデータセット市場：国別

第5章 LAMEAリアルワールドエビデンスソリューション市場：治療分野別

  • LAMEAの腫瘍学市場：国別
  • LAMEA心臓病学市場の国別推移
  • LAMEA神経学市場：国別
  • LAMEA糖尿病市場：国別
  • LAMEA呼吸器科の国別市場
  • LAMEAその他の国別市場

第6章 LAMEAリアルワールドエビデンスソリューションのエンドユーザー別市場

  • LAMEAヘルスケア企業市場：国別
  • LAMEAヘルスケアペイヤー市場：国別
  • LAMEAヘルスケアプロバイダの国別市場
  • LAMEAその他の国別市場

第7章：LAMEAリアルワールドエビデンスソリューションの用途別市場

  • LAMEA医薬品開発・承認市場の国別推移
  • LAMEA医療機器開発・承認市場：国別
  • LAMEAの償還/補償と規制上の意思決定市場：国別
  • LAMEAの市販後安全性・有害事象モニタリング市場：国別

第8章 LAMEAのリアルワールドエビデンスソリューションの国別市場

  • ブラジルのリアルワールドエビデンスソリューション市場
    • ブラジルのリアルワールドエビデンスソリューション市場：コンポーネント別
    • ブラジルのリアルワールドエビデンスソリューション市場：治療分野別
    • ブラジルのリアルワールドエビデンスソリューション市場（エンドユーザー別）
    • ブラジルのリアルワールドエビデンスソリューション市場：用途別
  • アルゼンチンのリアルワールドエビデンスソリューション市場
    • アルゼンチンのリアルワールドエビデンスソリューションズ市場：コンポーネント別
    • アルゼンチンのリアルワールドエビデンスソリューション市場（治療分野別）
    • アルゼンチンのリアルワールドエビデンスソリューション市場（エンドユーザー別）
    • アルゼンチンのリアルワールドエビデンスソリューションズ市場：用途別
  • UAEリアルワールドエビデンスソリューションズ市場
    • UAEのリアルワールドエビデンスソリューション市場：コンポーネント別
    • UAEのリアルワールドエビデンスソリューションの治療分野別市場
    • UAEリアルワールドエビデンスソリューションズのエンドユーザー別市場
    • UAEのリアルワールドエビデンスソリューションの用途別市場
  • サウジアラビアのリアルワールドエビデンスソリューション市場
    • サウジアラビアのリアルワールドエビデンスソリューション市場：コンポーネント別
    • サウジアラビアのリアルワールドエビデンスソリューション市場（治療分野別）
    • サウジアラビアのリアルワールドエビデンスソリューションズ市場：エンドユーザー別
    • サウジアラビアのリアルワールドエビデンスソリューションズ市場：用途別
  • 南アフリカのリアルワールドエビデンスソリューション市場
    • 南アフリカのリアルワールドエビデンスソリューション市場：コンポーネント別
    • 南アフリカのリアルワールドエビデンスソリューション市場：治療分野別
    • 南アフリカのリアルワールドエビデンスソリューション市場（エンドユーザー別）
    • 南アフリカのリアルワールドエビデンスソリューション市場：用途別
  • ナイジェリアのリアルワールドエビデンスソリューション市場
    • ナイジェリアのリアルワールドエビデンスソリューション市場：コンポーネント別
    • ナイジェリアのリアルワールドエビデンスソリューション市場：治療分野別
    • ナイジェリアのリアルワールドエビデンスソリューション市場：エンドユーザー別
    • ナイジェリアのリアルワールドエビデンスソリューション市場（用途別）
  • 世界のその他の地域（LAMEA）のリアルワールドエビデンスソリューション市場
    • 世界のその他の地域：リアルワールドエビデンスソリューションのコンポーネント別市場
    • LAMEA諸国のその他のリアルワールドエビデンスソリューション市場：治療分野別
    • LAMEAのその他の地域：リアルワールドエビデンスソリューションのエンドユーザー別市場
    • LAMEAのその他の地域のリアルワールドエビデンスソリューション市場：アプリケーション別

第9章：企業プロファイル

  • IBM Corporation
  • Oracle Corporation
  • PPD, Inc.（Thermo Fisher Scientific, Inc.）
  • UnitedHealth Group, Inc.（Optum, Inc.）
  • Syneos Health, Inc.
  • IQVIA Holdings, Inc.
  • Medpace Holdings, Inc.
  • ICON plc
  • PerkinElmer, Inc.
  • Parexel International Corporation（Phoenix Parentco, Inc.）
図表

LIST OF TABLES

  • TABLE 1 LAMEA Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 2 LAMEA Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 3 LAMEA Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 4 LAMEA Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 5 LAMEA Services Market by Country, 2018 - 2021, USD Million
  • TABLE 6 LAMEA Services Market by Country, 2022 - 2028, USD Million
  • TABLE 7 LAMEA Data Set Market by Country, 2018 - 2021, USD Million
  • TABLE 8 LAMEA Data Set Market by Country, 2022 - 2028, USD Million
  • TABLE 9 LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 10 LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 11 LAMEA Oncology Market by Country, 2018 - 2021, USD Million
  • TABLE 12 LAMEA Oncology Market by Country, 2022 - 2028, USD Million
  • TABLE 13 LAMEA Cardiology Market by Country, 2018 - 2021, USD Million
  • TABLE 14 LAMEA Cardiology Market by Country, 2022 - 2028, USD Million
  • TABLE 15 LAMEA Neurology Market by Country, 2018 - 2021, USD Million
  • TABLE 16 LAMEA Neurology Market by Country, 2022 - 2028, USD Million
  • TABLE 17 LAMEA Diabetes Market by Country, 2018 - 2021, USD Million
  • TABLE 18 LAMEA Diabetes Market by Country, 2022 - 2028, USD Million
  • TABLE 19 LAMEA Respiratory Market by Country, 2018 - 2021, USD Million
  • TABLE 20 LAMEA Respiratory Market by Country, 2022 - 2028, USD Million
  • TABLE 21 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 22 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 23 LAMEA Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 24 LAMEA Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 25 LAMEA Healthcare Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 26 LAMEA Healthcare Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 27 LAMEA Healthcare Payers Market by Country, 2018 - 2021, USD Million
  • TABLE 28 LAMEA Healthcare Payers Market by Country, 2022 - 2028, USD Million
  • TABLE 29 LAMEA Healthcare Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 30 LAMEA Healthcare Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 33 LAMEA Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 34 LAMEA Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 35 LAMEA Drug Development & Approvals Market by Country, 2018 - 2021, USD Million
  • TABLE 36 LAMEA Drug Development & Approvals Market by Country, 2022 - 2028, USD Million
  • TABLE 37 LAMEA Medical Device Development & Approvals Market by Country, 2018 - 2021, USD Million
  • TABLE 38 LAMEA Medical Device Development & Approvals Market by Country, 2022 - 2028, USD Million
  • TABLE 39 LAMEA Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2018 - 2021, USD Million
  • TABLE 40 LAMEA Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2022 - 2028, USD Million
  • TABLE 41 LAMEA Post Market Safety & Adverse Events Monitoring Market by Country, 2018 - 2021, USD Million
  • TABLE 42 LAMEA Post Market Safety & Adverse Events Monitoring Market by Country, 2022 - 2028, USD Million
  • TABLE 43 LAMEA Real World Evidence Solutions Market by Country, 2018 - 2021, USD Million
  • TABLE 44 LAMEA Real World Evidence Solutions Market by Country, 2022 - 2028, USD Million
  • TABLE 45 Brazil Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 46 Brazil Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 47 Brazil Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 48 Brazil Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 49 Brazil Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 50 Brazil Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 51 Brazil Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 52 Brazil Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 53 Brazil Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 54 Brazil Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 55 Argentina Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 56 Argentina Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 57 Argentina Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 58 Argentina Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 59 Argentina Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 60 Argentina Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 61 Argentina Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 62 Argentina Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 63 Argentina Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 64 Argentina Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 65 UAE Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 66 UAE Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 67 UAE Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 68 UAE Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 69 UAE Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 70 UAE Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 71 UAE Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 72 UAE Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 73 UAE Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 74 UAE Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 75 Saudi Arabia Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 76 Saudi Arabia Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 77 Saudi Arabia Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 78 Saudi Arabia Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 79 Saudi Arabia Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 80 Saudi Arabia Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 81 Saudi Arabia Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 82 Saudi Arabia Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 83 Saudi Arabia Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 84 Saudi Arabia Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 85 South Africa Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 86 South Africa Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 87 South Africa Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 88 South Africa Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 89 South Africa Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 90 South Africa Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 91 South Africa Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 92 South Africa Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 93 South Africa Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 94 South Africa Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 95 Nigeria Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 96 Nigeria Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 97 Nigeria Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 98 Nigeria Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 99 Nigeria Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 100 Nigeria Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 101 Nigeria Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 102 Nigeria Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 103 Nigeria Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 104 Nigeria Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 105 Rest of LAMEA Real World Evidence Solutions Market, 2018 - 2021, USD Million
  • TABLE 106 Rest of LAMEA Real World Evidence Solutions Market, 2022 - 2028, USD Million
  • TABLE 107 Rest of LAMEA Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
  • TABLE 108 Rest of LAMEA Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
  • TABLE 109 Rest of LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
  • TABLE 110 Rest of LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
  • TABLE 111 Rest of LAMEA Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
  • TABLE 112 Rest of LAMEA Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
  • TABLE 113 Rest of LAMEA Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
  • TABLE 114 Rest of LAMEA Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
  • TABLE 115 Key information - IBM Corporation
  • TABLE 116 Key Information - Oracle Corporation
  • TABLE 117 Key Information - PPD, Inc.
  • TABLE 118 Key Information - UnitedHealth Group, Inc.
  • TABLE 119 Key Information - Syneos Health, Inc.
  • TABLE 120 Key information - IQVIA Holdings, Inc.
  • TABLE 121 key Information - Medpace Holdings, Inc.
  • TABLE 122 key Information - PerkinElmer, Inc.
  • TABLE 123 Key Information - PAREXEL International Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Swot analysis: IBM Corporation
  • FIG 3 SWOT analysis: Oracle Corporation
  • FIG 4 Swot analysis: thermo fisher scientific, inc.
目次

The Latin America, Middle East and Africa Real World Evidence Solutions Market would witness market growth of 10.7% CAGR during the forecast period (2022-2028).

RWE is being utilized by pharma in more novel ways. RWE is used by some for clinical trial planning and recruiting. In contrast, others use it for post-market safety and unfavorable event monitoring or financial analyses relating to payer reimbursement. Some companies are incorporating ways to continuous learning into their lifecycle of product development.

Additionally, digital health innovation has considerably improved wearable technology's capabilities, which has led to a rise in the usage of recent technological advancements in clinical studies. More than 1,000 completed or continuing clinical research involving wearables were listed in the ClinicalTrials.gov database, mainly in oncology, neuroscience, and respiratory and metabolic illnesses. These developments are fostering the market for real-world evidence solutions.

The regional healthcare industry's future is shaped by several elements, which is why the trend is altering. Rising healthcare costs, shifting population & disease demographics, increased healthcare quality emphasis, medical data digitization, rising demand for regional clinical & economic data, and a general influence of worldwide trends in the medical industry are some of the other factors. However, for the region to fully benefit from RWE in treatment decisions, it must overcome some obstacles, such as accepting the worth that RWE puts to healthcare decisions, and fostering trust among stakeholders. Additionally, establishment of the validity & reliability of the databases utilized to generate RWE, investment in the generation of local data, and improving technical capabilities would benefit the market. These factors would further proliferate the undertaking of high-quality RWE research while protecting patient confidentiality. These rising healthcare sector would drive the demand of Real World Evidence Solutions Market in LAMEA.

The Brazil market dominated the LAMEA Real World Evidence Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $933 million by 2028.The Argentina market is exhibiting a CAGR of 11.3% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 10.4% during (2022 - 2028).

Based on Component, the market is segmented into Services and Data Set. Based on Therapeutic Area, the market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory and Others. Based on End-user, the market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers and Others. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making and Post Market Safety & Adverse Events Monitoring. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.

Scope of the Study

Market Segments covered in the Report:

By Component

  • Services
  • Data Set

By Therapeutic Area

  • Oncology
  • Cardiology
  • Neurology
  • Diabetes
  • Respiratory
  • Others

By End-user

  • Healthcare Companies
  • Healthcare Payers
  • Healthcare Providers
  • Others

By Application

  • Drug Development & Approvals
  • Medical Device Development & Approvals
  • Reimbursement/Coverage & Regulatory Decision Making
  • Post Market Safety & Adverse Events Monitoring

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • IBM Corporation
  • Oracle Corporation
  • Medpace Holdings, Inc.
  • IQVIA Holdings, Inc.
  • ICON plc
  • PerkinElmer, Inc.
  • Parexel International Corporation (Phoenix Parentco, Inc.)
  • PPD, Inc. (Thermo Fisher Scientific, Inc.)
  • UnitedHealth Group, Inc. (Optum, Inc.)
  • Syneos Health, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Real World Evidence Solutions Market, by Component
    • 1.4.2 LAMEA Real World Evidence Solutions Market, by Therapeutic Area
    • 1.4.3 LAMEA Real World Evidence Solutions Market, by End-user
    • 1.4.4 LAMEA Real World Evidence Solutions Market, by Application
    • 1.4.5 LAMEA Real World Evidence Solutions Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Scenario and Composition
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Real World Evidence Solutions Market

Chapter 4. LAMEA Real World Evidence Solutions Market by Component

  • 4.1 LAMEA Services Market by Country
  • 4.2 LAMEA Data Set Market by Country

Chapter 5. LAMEA Real World Evidence Solutions Market by Therapeutic Area

  • 5.1 LAMEA Oncology Market by Country
  • 5.2 LAMEA Cardiology Market by Country
  • 5.3 LAMEA Neurology Market by Country
  • 5.4 LAMEA Diabetes Market by Country
  • 5.5 LAMEA Respiratory Market by Country
  • 5.6 LAMEA Others Market by Country

Chapter 6. LAMEA Real World Evidence Solutions Market by End-user

  • 6.1 LAMEA Healthcare Companies Market by Country
  • 6.2 LAMEA Healthcare Payers Market by Country
  • 6.3 LAMEA Healthcare Providers Market by Country
  • 6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Real World Evidence Solutions Market by Application

  • 7.1 LAMEA Drug Development & Approvals Market by Country
  • 7.2 LAMEA Medical Device Development & Approvals Market by Country
  • 7.3 LAMEA Reimbursement/Coverage & Regulatory Decision Making Market by Country
  • 7.4 LAMEA Post Market Safety & Adverse Events Monitoring Market by Country

Chapter 8. LAMEA Real World Evidence Solutions Market by Country

  • 8.1 Brazil Real World Evidence Solutions Market
    • 8.1.1 Brazil Real World Evidence Solutions Market by Component
    • 8.1.2 Brazil Real World Evidence Solutions Market by Therapeutic Area
    • 8.1.3 Brazil Real World Evidence Solutions Market by End-user
    • 8.1.4 Brazil Real World Evidence Solutions Market by Application
  • 8.2 Argentina Real World Evidence Solutions Market
    • 8.2.1 Argentina Real World Evidence Solutions Market by Component
    • 8.2.2 Argentina Real World Evidence Solutions Market by Therapeutic Area
    • 8.2.3 Argentina Real World Evidence Solutions Market by End-user
    • 8.2.4 Argentina Real World Evidence Solutions Market by Application
  • 8.3 UAE Real World Evidence Solutions Market
    • 8.3.1 UAE Real World Evidence Solutions Market by Component
    • 8.3.2 UAE Real World Evidence Solutions Market by Therapeutic Area
    • 8.3.3 UAE Real World Evidence Solutions Market by End-user
    • 8.3.4 UAE Real World Evidence Solutions Market by Application
  • 8.4 Saudi Arabia Real World Evidence Solutions Market
    • 8.4.1 Saudi Arabia Real World Evidence Solutions Market by Component
    • 8.4.2 Saudi Arabia Real World Evidence Solutions Market by Therapeutic Area
    • 8.4.3 Saudi Arabia Real World Evidence Solutions Market by End-user
    • 8.4.4 Saudi Arabia Real World Evidence Solutions Market by Application
  • 8.5 South Africa Real World Evidence Solutions Market
    • 8.5.1 South Africa Real World Evidence Solutions Market by Component
    • 8.5.2 South Africa Real World Evidence Solutions Market by Therapeutic Area
    • 8.5.3 South Africa Real World Evidence Solutions Market by End-user
    • 8.5.4 South Africa Real World Evidence Solutions Market by Application
  • 8.6 Nigeria Real World Evidence Solutions Market
    • 8.6.1 Nigeria Real World Evidence Solutions Market by Component
    • 8.6.2 Nigeria Real World Evidence Solutions Market by Therapeutic Area
    • 8.6.3 Nigeria Real World Evidence Solutions Market by End-user
    • 8.6.4 Nigeria Real World Evidence Solutions Market by Application
  • 8.7 Rest of LAMEA Real World Evidence Solutions Market
    • 8.7.1 Rest of LAMEA Real World Evidence Solutions Market by Component
    • 8.7.2 Rest of LAMEA Real World Evidence Solutions Market by Therapeutic Area
    • 8.7.3 Rest of LAMEA Real World Evidence Solutions Market by End-user
    • 8.7.4 Rest of LAMEA Real World Evidence Solutions Market by Application

Chapter 9. Company Profiles

  • 9.1 IBM Corporation
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional & Segmental Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 Oracle Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 SWOT Analysis
  • 9.3 PPD, Inc. (Thermo Fisher Scientific, Inc.)
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 SWOT Analysis
  • 9.4 UnitedHealth Group, Inc. (Optum, Inc.)
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental Analysis
  • 9.5 Syneos Health, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Recent strategies and developments:
      • 9.5.4.1 Acquisition and Mergers:
  • 9.6 IQVIA Holdings, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Recent strategies and developments:
      • 9.6.4.1 Partnerships, Collaborations, and Agreements:
      • 9.6.4.2 Acquisition and Mergers:
  • 9.7 Medpace Holdings, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
  • 9.8 ICON plc
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Recent strategies and developments:
      • 9.8.4.1 Acquisition and Mergers:
  • 9.9 PerkinElmer, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Product Launches and Product Expansions:
  • 9.10. Parexel International Corporation (Phoenix Parentco, Inc.)
    • 9.10.1 Company Overview
    • 9.10.2 Recent strategies and developments:
      • 9.10.2.1 Partnerships, Collaborations, and Agreements: